Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Submitted by
admin
on April 28, 2017 - 10:32am
Source:
Marketwatch
News Tags:
Bristol-Myers Squibb
China
hepatitis C
Daklinza
Headline:
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Do Not Allow Advertisers to Use My Personal information
